Overview

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
In this survey, to collect the safety and efficacy information of Bazedoxifene in daily medical practice will be examined. In addition, the necessity of special Investigation and post-marketing clinical studies will be examined, while investigating unexpected adverse drug reactions during the survey period and understanding of the status of frequency of adverse drug reactions in daily medical practice.
Details
Lead Sponsor:
Pfizer
Treatments:
Bazedoxifene